» Articles » PMID: 37375540

Risk Factors for Hepatitis E Virus Infection and Eating Habits in Kidney Transplant Recipients

Abstract

There is a significant risk for ongoing and treatment-resistant courses of hepatitis E virus (HEV) infection in patients after solid organ transplantation. The aim of this study was to identify risk factors for the development of hepatitis E, including the dietary habits of patients. We conducted a retrospective single-center study with 59 adult kidney and combined kidney transplant recipients who were diagnosed with HEV infection between 2013 and 2020. The outcomes of HEV infections were analyzed during a median follow-up of 4.3 years. Patients were compared with a control cohort of 251 transplant patients with elevated liver enzymes but without evidence of an HEV infection. Patients' alimentary exposures during the time before disease onset or diagnosis were assessed. Previous intense immunosuppression, especially treatment with high-dose steroids and rituximab, was a significant risk factor to acquire hepatitis E after solid organ transplantation. Only 11 out of 59 (18.6%) patients reached remission without further ribavirin (RBV) treatment. A total of 48 patients were treated with RBV, of which 19 patients (39.6%) had either viral rebounds after the end of treatment or did not reach viral clearance at all. Higher age (>60 years) and a BMI ≤ 20 kg/m were risk factors for RBV treatment failure. Deterioration in kidney function with a drop in eGFR ( = 0.046) and a rise in proteinuria was more common in patients with persistent hepatitis E viremia. HEV infection was associated with the consumption of undercooked pork or pork products prior to infection. Patients also reported processing raw meat with bare hands at home more frequently than the controls. Overall, we showed that the intensity of immunosuppression, higher age, a low BMI and the consumption of undercooked pork meat correlated with the development of hepatitis E.

Citing Articles

Hepatitis E Infection in Immunocompromised Patients Previously Treated With Rituximab.

Kogias D, Gavriilidis E, Antoniadou C, Skeva A, Kafalis N, Tsilingiris D J Viral Hepat. 2025; 32(3):e70005.

PMID: 39927678 PMC: 11809126. DOI: 10.1111/jvh.70005.

References
1.
Wenzel J, Preiss J, Schemmerer M, Huber B, Plentz A, Jilg W . Detection of hepatitis E virus (HEV) from porcine livers in Southeastern Germany and high sequence homology to human HEV isolates. J Clin Virol. 2011; 52(1):50-4. DOI: 10.1016/j.jcv.2011.06.006. View

2.
Kamar N, Garrouste C, Haagsma E, Garrigue V, Pischke S, Chauvet C . Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011; 140(5):1481-9. DOI: 10.1053/j.gastro.2011.02.050. View

3.
Dietrich C, Bamber J, Berzigotti A, Bota S, Cantisani V, Castera L . EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version). Ultraschall Med. 2017; 38(4):e16-e47. DOI: 10.1055/s-0043-103952. View

4.
Dalton H, Kamar N . Treatment of hepatitis E virus. Curr Opin Infect Dis. 2016; 29(6):639-644. DOI: 10.1097/QCO.0000000000000316. View

5.
Wallace S, Swann R, Donnelly M, Kemp L, Guaci J, Murray A . Mortality and morbidity of locally acquired hepatitis E in the national Scottish cohort: a multicentre retrospective study. Aliment Pharmacol Ther. 2020; 51(10):974-986. DOI: 10.1111/apt.15704. View